This UK Biotech uses CRISPR-Cas9 Against Bacterial Resistance – Labiotech.eu (blog)
|
This UK Biotech uses CRISPR-Cas9 Against Bacterial Resistance
Labiotech.eu (blog) Swiss Bioversys is testing a similar approach, although the biotech's platform is based on small molecules. Also, Nemesis' technology represents yet another exciting therapeutic application of the CRISPR-Cas9 system. Because the endonuclease is … |
